Dermata Therapeutics, Inc. (DRMAW) — DEF 14A Filings
All DEF 14A filings from Dermata Therapeutics, Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Dermata Therapeutics Schedules 2024 Annual Meeting of Stockholders for May 7
— Mar 26, 2024 Risk: low
Dermata Therapeutics, Inc. (DRMAW) filed a Proxy Statement (DEF 14A) with the SEC on March 26, 2024. Dermata Therapeutics, Inc. will hold its Annual Meeting of
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX